Informed Prostate Cancer Patient Support

Summary This article describes a Phase II clinical trial called SBRT-SG 05 that evaluated the use of stereotactic body radiation therapy (SBRT) combined with androgen deprivation therapy (ADT) in patients with oligometastatic prostate cancer. Here are the key points: 1. Study design: - Two cohorts:   1) Main cohort of 67 patients with hormone-sensitive prostate cancer   2) Exploratory cohort of 14 patients with castration-resistant prostate cancer - Patients received SBRT to metastatic lesions and ADT for at least 24 months - Median follow-up was 40 months 2. Main results: - 3-year local recurrence-free survival: 92.5% (62/67) in main cohort, 85.7% (12/14) in exploratory cohort - In main cohort at 3 years:   - Biochemical relapse-free survival: 50.6%   - Metastasis progression-free survival: 67% - Exploratory cohort had lower metastasis progression-free survival rates 3. Toxicity: - No grade III or higher toxicity - Only 2 patients (2.4%) developed grade II toxicity 4. Conclusions: - T

Cancer screening tech startup Ezra opens two locations in Seattle area – GeekWire geekwire.com Taylor Soper Ezra produces reports for customers after they do a full-body MRI scan. (Ezra Image) Ezra , a New York City-based health technology startup offering cancer screening, opened two locations in the Seattle area this week. Founded in 2018, Ezra has 37 locations across the U.S. where patients can get full-body MRI scans in 30 minutes that the company says can detect cancer and more than 500 other conditions. Ezra says it has found early cancer in 6% of its customers. Ezra is one of several new tech startups selling full-body scans that use latest AI and machine learning technology, with the promise of catching disease early. Ezra says its tech allows MRI machines to take photos at faster speeds and can enhance the quality of the

ChatGPT can help guide and empower patients after prostate cancer diagnosis | Prostate Cancer and Prostatic Diseases nature.com Roberts, Matthew J.   Clinical Harry Collin ,  Kandice Keogh , Marnique Basto , Stacy Loeb &  Matthew J. Roberts   Prostate Cancer and Prostatic Diseases ( 2024 ) Cite this article Abstract Background/Objectives Patients often face uncertainty about what they should know after prostate cancer diagnosis. Web-based information is common but is at risk of being of poor quality or readability. Subjects/Methods We used ChatGPT, a freely available Artificial intelligence